HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq 04:00:00 2023-12-07 pm EST Intraday chart for HealthEquity, Inc. 5-day change 1st Jan Change
67.72 USD -2.32% +1.04% +9.86%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Deutsche Bank Raises HealthEquity Price Target to $88 From $85, Maintains Buy Rating MT
Wells Fargo Adjusts HealthEquity's Price Target to $93 From $89, Maintains Overweight Rating MT
HealthEquity's Fiscal Q3 Non-GAAP Earnings, Revenue Rise MT
Transcript : HealthEquity, Inc., Q3 2024 Earnings Call, Dec 05, 2023 CI
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 Revenue $249.2M, vs. Street Est of $243.6M MT
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 EPS $0.60, vs. Street Est of $0.50 MT
HealthEquity Guides For FY 2024 EPS of $2.08-$2.16 on Revenue of $985-$995 Million, vs CIQ Analyst Consensus of $2.03/Share on Revenue of $989 Million MT
HealthEquity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025 CI
North American Morning Briefing : China Outlook -2- DJ
Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating MT
Healthequity Insider Sold Shares Worth $143,704, According to a Recent SEC Filing MT
Healthequity Insider Sold Shares Worth $365,923, According to a Recent SEC Filing MT
Healthequity Insider Sold Shares Worth $464,896, According to a Recent SEC Filing MT
North American Morning Briefing : Stock Futures -2- DJ
Baird Upgrades HealthEquity to Outperform From Neutral, Raises Price Target to $87 From $79 MT
HealthEquity, Inc. entered into a definitive agreement to acquire BenefitWallet?s Health Savings Account portfolio from Conduent Business Services, LLC for $425 million. CI
Deutsche Bank Adjusts HealthEquity Price Target to $72 From $71, Maintains Buy Rating MT
RBC Lifts PT on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance, Keeps Outperform Rating MT
Baird Adjusts Price Target on HealthEquity to $79 From $77, Maintains Neutral Rating MT
Barrington Raises PT on HealthEquity to $85 From $80 After Fiscal Q2 Results Surpass Expectations, Maintains Outperform Rating MT
RBC Lifts Price Target on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance Boost, Keeps Outperform Rating MT
Transcript : HealthEquity, Inc., Q2 2024 Earnings Call, Sep 05, 2023 CI
HealthEquity Fiscal Q2 Adjusted Profit, Revenue Increase; Boosts Fiscal 2024 Outlook MT
HealthEquity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023 CI
Chart HealthEquity, Inc.
More charts
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.
Calendar
2024-02-22 - Investor Day
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
67.72USD
Average target price
86.83USD
Spread / Average Target
+28.22%
Consensus
1st Jan change Capi.
+9.86% 5 810 M $
+54.68% 2757 B $
+67.29% 81 236 M $
+61.52% 70 592 M $
+30.84% 62 135 M $
+45.98% 48 476 M $
+168.22% 37 471 M $
+53.42% 33 723 M $
+48.08% 26 226 M $
+75.41% 25 451 M $
Other Software
  1. Stock
  2. Equities
  3. Stock HealthEquity, Inc. - Nasdaq
  4. News HealthEquity, Inc.
  5. Baird Upgrades HealthEquity to Outperform From Neutral, Raises Price Target to $87 From $79
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer